diabetes

Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga
Dexcom’s CEO claims company has a ‘compelling’ case for broader CGM use
MedCity News
Wed, 06/30/21 - 10:10 pm
DexCom
devices
continuous glucose monitoring
diabetes
type 1 diabetes
type 2 diabetes
Medtronic smart insulin pen improved time in target blood glucose levels: study
Medtech Dive
Wed, 06/30/21 - 10:57 am
Medtronic
devices
InPen
insulin pen
diabetes
Eli Lilly will consider lower insulin prices, CEO says
Beckers Hospital Review
Wed, 06/30/21 - 12:19 am
Eli Lilly
David Ricks
Pharma CEOs
insulin
drug prices
diabetes
Walmart launches private label insulin brand at steep discounts for diabetes patients
Yahoo Finance
Wed, 06/30/21 - 12:16 am
Walmart
diabetes
insulin
ViaCyte reports positive cell replacement result for diabetes
Biopharma Reporter
Tue, 06/29/21 - 10:50 am
ViaCyte
islet cell replacement
type 1 diabetes
diabetes
ADA 2021: After strong showing for Soliqua against premixed insulin, Sanofi exec expects 'a lot of interest' among doctors
Fierce Pharma
Mon, 06/28/21 - 10:53 am
ADA
diabetes
Sanofi
Soliqua
ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom
Fierce Pharma
Sun, 06/27/21 - 10:57 pm
Novo Nordisk
Ozempic
Eli Lilly
Rybelsus
Trulicity
diabetes
type 2 diabetes
ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes
Fierce Pharma
Fri, 06/25/21 - 12:16 pm
AstraZeneca
Bydureon
diabetes
pediatric
type 2 diabetes
clinical trials
Medicare CGM eligibility widened in potential boon for Abbott, Dexcom
Medtech Dive
Mon, 06/21/21 - 10:56 am
Medicare
CMS
diabetes
continuous glucose monitoring
blood glucose monitoring
devices
DexCom
Abbott Labs
After a decade in the type 2 diabetes game, Fractyl Laboratories recharges with a fresh $100M and a new name
Endpoints
Wed, 06/16/21 - 11:45 am
Fractyl Labs
type 2 diabetes
diabetes
Mississippi first state to sue drugmakers, PBMs over 'egregiously inflated' insulin costs
Beckers Hospital Review
Tue, 06/15/21 - 11:32 pm
insulin
diabetes
PBMs
Mississippi
Carbon Health buys virtual diabetes clinic firm Steady Health
Pharmaforum
Tue, 06/8/21 - 11:02 am
Carbon Health
digital health
diabetes
M&A
2nd time's the charm? Novo Nordisk reups bid for high-dose Ozempic after March FDA snub
Fierce Pharma
Sat, 05/29/21 - 05:04 pm
Novo Nordisk
Ozempic
FDA
diabetes
Provention Bio, in need of AdComm's support for diabetes drug, may have what it needs to satisfy the FDA
Fierce Biotech
Tue, 05/25/21 - 11:52 pm
Provention Bio
FDA
advisory panels
diabetes
teplizumab
Sirona Biochem's Innovations in Biotechnology Lead to Safer, More Effective Cosmetic and Pharmaceutical Active Ingredients
CP WIre
Tue, 05/25/21 - 11:10 am
Sirona Biochem
biotech
innovation
cosmetic
diabetes
active pharmaceutical ingredients
Lilly leads the big pharma pack on pipeline value
EP Vantage
Tue, 05/25/21 - 11:04 am
Eli Lilly
diabetes
Alzheimer's disease
GSK
AbbVie
Eli Lilly wraps up fifth and final tirzepatide PhIII trial, claiming a win over Sanofi's Lantus. The FDA awaits
Endpoints
Thu, 05/20/21 - 11:11 am
Eli Lilly
diabetes
Trulicity
tirzepatide
clinical trials
Bigfoot Biomedical gets FDA clearance for ‘smart’ insulin pen caps
MedCity News
Wed, 05/12/21 - 11:50 pm
Bigfoot Biomedical
devices
FDA
smart insulin pen cap
diabetes
Diabetes tech companies continue 2020's success with Q1 growth. Investors seem unimpressed.
Medtech Dive
Wed, 05/12/21 - 10:48 am
devices
diabetes
Medtech
earnings
DexCom
Insulet
Tandem Diabetes
Bigfoot Biomedical

Pages